Menu

勃林格殷格翰的能倍乐进入医保了吗?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Developed by Boehringer Ingelheim, it has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with chronic obstructive pulmonary disease (COPD), making it easier for them to breathe. So, has Boehringer Ingelheim’s Respimat entered health insurance?

Respimat has been on the market in China since 2014, so patients only need to rely on pharmacies to buy Respimat at major domestic pharmacies. In addition, Respimat has been included in Category B of medical insurance, but the reimbursement standards of medical insurance vary from place to place. Compared with the domestic price, it is still relatively expensive. It is understood that the current relatively low price of Respimat is about 170 US dollars per box. Patients in need can buy it abroad or obtain the medicine through domestic professional overseas medical service organizations (such as Medical Companion Travel), and have it shipped directly to their homes, ensuring authenticity.

Boehringer Ingelheim is a pharmaceutical company dedicated to human biopharmaceutical chemistry and animal health products. It is also the world's largest privately held pharmaceutical company. Boehringer Ingelheim's main research areas include: immune and respiratory diseases, cardiovascular and metabolic diseases, central nervous system diseases, and tumors. Boehringer Ingelheim has a complete biopharmaceutical industry chain, from genetic engineering of cells to manufacturing, and commercial production of off-the-shelf medicines for external industrial customers.

The recommended dose of Respimat is once a day, with two sprays each time. The effect of Respimat can last for 24 hours. Patients are advised not to overdose.

Respimat should be used at the same time every day, and, since COPD is a long-term disease, Respimat can be used every day, not just when you have breathing problems.

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that causes shortness of breath and coughing. Respimat helps open the airways, making it easier for air to move in and out of the lungs. Normal use can also relieve persistent shortness of breath caused by the disease and help minimize the impact of the disease on daily life.

Recommended related hot articles: /newsDetail/90474.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。